Terug
Dagbereik
€ 10,01
€ 10,63
52-Weeksbereik
€ 7,11
€ 11,17
Volume
1.561.412
50D / 200D Gem.
€ 10,10
/
€ 9,54
Vorige Slotkoers
€ 9,91
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -19,9 | 0,4 |
| P/B | 0,9 | 2,9 |
| ROE % | -4,6 | 3,7 |
| Net Margin % | -2,2 | 3,8 |
| Rev Growth 5Y % | 7,2 | 10,0 |
| D/E | 1,3 | 0,2 |
Belangrijkste Punten
Revenue grew 7,23% annually over 5 years — modest growth
Earnings declined -178,29% over the past year
Generating 219,38M in free cash flow
PEG of 0,10 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,72%
ROIC of 4,08% — low return on invested capital
Groei
Revenue Growth (5Y)
7,23%
Revenue (1Y)-0,49%
Earnings (1Y)-178,29%
FCF Growth (3Y)23,77%
Kwaliteit
Return on Equity
-4,58%
ROIC4,08%
Net Margin-2,18%
Op. Margin5,74%
Veiligheid
Debt / Equity
1,25
Current Ratio1,02
Interest Coverage1,76
Waardering
P/E Ratio
-19,91
P/B Ratio0,93
EV/EBITDA17,21
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,49% | Revenue Growth (3Y) | 0,70% |
| Earnings Growth (1Y) | -178,29% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 7,23% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,24B | Net Income (TTM) | -70,79M |
| ROE | -4,58% | ROA | -1,64% |
| Gross Margin | 17,52% | Operating Margin | 5,74% |
| Net Margin | -2,18% | Free Cash Flow (TTM) | 219,38M |
| ROIC | 4,08% | FCF Growth (3Y) | 23,77% |
| Safety | |||
| Debt / Equity | 1,25 | Current Ratio | 1,02 |
| Interest Coverage | 1,76 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -19,91 | P/B Ratio | 0,93 |
| P/S Ratio | 0,43 | PEG Ratio | 0,10 |
| EV/EBITDA | 17,21 | Dividend Yield | 0,00% |
| Market Cap | 1,41B | Enterprise Value | 3,21B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,24B | 3,26B | 3,20B | 2,97B | 2,45B |
| Net Income | -70,79M | 90,42M | -678,90M | 69,32M | 156,18M |
| EPS (Diluted) | -0,52 | 0,61 | -5,31 | 0,50 | 0,67 |
| Gross Profit | 568,56M | 681,09M | 681,77M | 417,43M | 445,61M |
| Operating Income | 186,27M | 263,73M | -598,40M | 190,41M | 225,61M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4,32B | 4,49B | 4,51B | 5,22B | 5,25B |
| Total Liabilities | 2,79B | 2,91B | 3,04B | 3,06B | 3,18B |
| Shareholders' Equity | 1,52B | 1,57B | 1,46B | 2,15B | 2,06B |
| Total Debt | 1,90B | 2,13B | 2,29B | 2,33B | 2,37B |
| Cash & Equivalents | 106,14M | 109,75M | 77,13M | 46,27M | 149,63M |
| Current Assets | 728,90M | 755,79M | 649,02M | 585,31M | 670,06M |
| Current Liabilities | 712,39M | 566,99M | 537,00M | 456,21M | 499,81M |